Catalyst Wire Dossier Catalyst Wire Dossier

RGD peptide

Arginyl-Glycyl-Aspartic acid (RGD) peptide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGD peptide, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement [NA]

See pricing